Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Medicated Skin Care in

Dermatologicals in the US

23 pages, Feb 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Dermatologicals faces increasing competition from natural alternatives

Although dermatologicals saw a positive performance between 2017 and 2018, gains in some categories were partly offset by losses in others, such as antiparasitics/lice (head and body) treatments, vaginal antifungals and nappy (diaper) rash treatments. Within antiparasitics/lice treatments, parents are eschewing medication-based treatments for either natural, herbal solutions or private businesses that specialise in lice removal in the home.

A shift towards prevention leads to an overlap with beauty and personal care

One of the most important trends driving sales across several consumer goods categories in the US is consumers’ interest in prevention. Whilst in the past, consumers were content to treat specific health problems with OTC remedies as they occurred, they are now more interested in preventing such problems before they occur.

Cold sore treatments and topical germicidals/antiseptics push growth

Even though many categories within dermatologicals saw declines in sales between 2017 and 2018, strong growth in cold sore treatments, topical germicidals/antiseptics and antipruritics in particular pushed the category to an overall positive performance over the year, and from a much greater base in the case of antipruritics. The selected success of some categories within dermatologicals illustrates the key point that whilst many are suffering either due to the competition from natural products or the overlap with the beauty industry, consumer demand remains strong in other categories and will continue to drive sales over the forecast period.

COMPETITIVE LANDSCAPE

Chattem (Sanofi) sees success in antipruritics

Chattem’s antipruritics brands Cortizone and Gold Bond both saw strong value growth in 2018, driven by popularity amongst consumers as an anti-itch and eczema relief brand in the case of Cortizone, and by brand extensions and reformulations in the case of Gold Bond. Both brands have established trust with the consumer base and are considered both safe and efficacious, which contributed to their success in dermatologicals.

Doctor recommendations are key in the success of Neosporin Plus

Neosporin Plus from McNeil Consumer Healthcare (Johnson & Johnson) drove sales in the fragmented category of topical germicidals/antiseptics and easily made up for the sales lost by partner brand Neosporin. The addition of the analgesic pramoxine hydrochloride appealed to consumers looking for antibacterial and pain relief products in combination, particularly when treating the common injuries faced by children and toddlers.

The strong cold and flu season contributes to growth in cold sore treatments

Although most of the impact of the severe cold and flu season of 2017-2018 on consumer health was seen in cough and cold remedies, cold sore treatments also saw notable growth, due to the harsher weather and increased impact of circulating viruses. GSK Consumer Healthcare’s Abreva brand maintained its dominance in cold sore treatments in 2018, as consumers view the brand as synonymous with the condition.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Medicated Skin Care Market Sample Report Medicated Skin Care Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in USA with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in USA, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in USA market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Medicated Skin Care in USA?
What are the major brands in USA?
What are the most popular formats for acne treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Dermatologicals in the US - Category analysis

HEADLINES

PROSPECTS

Dermatologicals faces increasing competition from natural alternatives

A shift towards prevention leads to an overlap with beauty and personal care

Cold sore treatments and topical germicidals/antiseptics push growth

COMPETITIVE LANDSCAPE

Chattem (Sanofi) sees success in antipruritics

Doctor recommendations are key in the success of Neosporin Plus

The strong cold and flu season contributes to growth in cold sore treatments

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Players innovate to follow consumers’ changing lifestyles

Positive growth in 2018, although at a slower pace

A fragmented competitive environment

The move towards internet retailing

Continued growth for consumer health, despite maturity and concern about changes

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Megatrends

Country Report

Dermatologicals in the US

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Dermatologicals faces increasing competition from natural alternatives

A shift towards prevention leads to an overlap with beauty and personal care

Cold sore treatments and topical germicidals/antiseptics push growth

COMPETITIVE LANDSCAPE

Chattem (Sanofi) sees success in antipruritics

Doctor recommendations are key in the success of Neosporin Plus

The strong cold and flu season contributes to growth in cold sore treatments

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Dermatologicals in the US - Category analysis

HEADLINES

PROSPECTS

Dermatologicals faces increasing competition from natural alternatives

A shift towards prevention leads to an overlap with beauty and personal care

Cold sore treatments and topical germicidals/antiseptics push growth

COMPETITIVE LANDSCAPE

Chattem (Sanofi) sees success in antipruritics

Doctor recommendations are key in the success of Neosporin Plus

The strong cold and flu season contributes to growth in cold sore treatments

CATEGORY DATA

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Players innovate to follow consumers’ changing lifestyles

Positive growth in 2018, although at a slower pace

A fragmented competitive environment

The move towards internet retailing

Continued growth for consumer health, despite maturity and concern about changes

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements (VDS) registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports